Related Experiment Videos
Carrier identification in X-linked immunodeficiency diseases
1Xi'an Children's Hospital, Xiguyuanxian, P. R. China.
Journal of Paediatrics and Child Health
|June 20, 1998
Summary
This study introduces a rapid PCR assay for identifying carriers of X-linked immunodeficiencies. The method detects non-random X inactivation (NRXI) to confirm carrier status in women and diagnose X-linked severe combined immunodeficiency (XSCID).
Area of Science:
- Immunology
- Genetics
- Molecular Biology
Background:
- X-linked immunodeficiency disorders (XLIDs) diagnosis can be challenging.
- Carrier identification is crucial for genetic counseling and family planning.
- Non-random X inactivation (NRXI) is a potential indicator in affected female carriers.
Purpose of the Study:
- To evaluate the utility of NRXI detection for carrier identification in X-linked severe combined immunodeficiency (XSCID) and X-linked hypogammaglobulinaemia (XLH).
- To identify carrier mothers of affected boys and infer X-linkage in unclear cases.
- To establish a rapid diagnostic method for XLIDs.
Main Methods:
- Utilized a polymerase chain reaction (PCR)-based assay.
- Amplified a polymorphic CAG repeat in the androgen receptor gene.
- Employed methylation-sensitive enzyme digestion (HpaII) to assess X chromosome inactivation status.
Main Results:
- Successfully identified heterozygosity in 77% (24/31) of female subjects.
- Demonstrated NRXI in lymphoid cells of obligate carriers for XSCID and XLH.
- Confirmed carrier status for XSCID in a mother, enabling diagnosis for her son.
Conclusions:
- The developed PCR assay is a rapid and effective method for carrier detection in X-linked immunodeficiencies.
- This approach aids in expanding the known phenotype of XSCID.
- Facilitates accurate diagnosis and genetic counseling for families affected by XLIDs.